HK1092180A1 - Methods for treating ischemic diseases - Google Patents

Methods for treating ischemic diseases

Info

Publication number
HK1092180A1
HK1092180A1 HK06112775A HK06112775A HK1092180A1 HK 1092180 A1 HK1092180 A1 HK 1092180A1 HK 06112775 A HK06112775 A HK 06112775A HK 06112775 A HK06112775 A HK 06112775A HK 1092180 A1 HK1092180 A1 HK 1092180A1
Authority
HK
Hong Kong
Prior art keywords
methods
ischemic diseases
treating ischemic
treating
diseases
Prior art date
Application number
HK06112775A
Other languages
English (en)
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Publication of HK1092180A1 publication Critical patent/HK1092180A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06112775A 2003-02-19 2006-11-21 Methods for treating ischemic diseases HK1092180A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003040806 2003-02-19
PCT/JP2004/000957 WO2004074494A1 (ja) 2003-02-19 2004-01-30 虚血疾患の治療方法

Publications (1)

Publication Number Publication Date
HK1092180A1 true HK1092180A1 (en) 2007-02-02

Family

ID=32905267

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06112775A HK1092180A1 (en) 2003-02-19 2006-11-21 Methods for treating ischemic diseases

Country Status (8)

Country Link
US (1) US20070036756A1 (ja)
EP (1) EP1600511A4 (ja)
JP (1) JPWO2004074494A1 (ja)
KR (1) KR20050111593A (ja)
CN (1) CN100402654C (ja)
CA (1) CA2516486A1 (ja)
HK (1) HK1092180A1 (ja)
WO (1) WO2004074494A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097988A1 (ja) * 2004-03-23 2005-10-20 Dnavec Research Inc. 組織の維持および／または修復に関連する骨髄関連細胞
EP1865992A2 (en) * 2005-03-31 2007-12-19 Mytogen Inc. Treatment for heart disease
KR20080103637A (ko) 2007-05-25 2008-11-28 주식회사 알앤엘바이오 지방유래 줄기세포를 함유하는 사지말단부 허혈성 질환의세포치료용 조성물
EP2473196B1 (en) * 2009-08-28 2017-05-31 The Cleveland Clinic Foundation Sdf-1 delivery for treating ischemic tissue
WO2012094560A2 (en) 2011-01-07 2012-07-12 Applied Genetic Technologies Corporation Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
SG10202000644TA (en) * 2014-04-07 2020-03-30 Mesoblast Int Sarl Improved Stem Cell Composition
US10588940B2 (en) * 2015-11-06 2020-03-17 Regeneron Pharmaceuticals, Inc. Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
JP6959369B2 (ja) * 2017-06-20 2021-11-02 エヌセイジ コーポレーション アンジオポエチン−１またはｖｅｇｆを分泌する幹細胞およびこれを含む心血管疾患の予防または治療用薬学組成物
KR102508657B1 (ko) 2021-02-17 2023-03-10 성균관대학교산학협력단 금-구리 나노입자를 유효성분으로 포함하는 허혈성 질환 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU729934B2 (en) * 1996-01-23 2001-02-15 Oxford Biomedica (Uk) Limited Retroviral vector and its use in gene therapy
JP2004516242A (ja) * 2000-07-26 2004-06-03 サイムド ライフ システムズ， インコーポレイテッド 心筋および骨格筋の虚血組織に骨髄由来の細胞移植をすることによる、治療を目的とした血管形成
CN1137993C (zh) * 2000-11-02 2004-02-11 上海兆安医学科技有限公司 骨形态发生蛋白重组腺病毒及其激发骨生成的方法
CA2449687A1 (en) * 2001-06-08 2002-12-19 Dnavec Research Inc. Vascular regeneration therapy
WO2005097988A1 (ja) * 2004-03-23 2005-10-20 Dnavec Research Inc. 組織の維持および／または修復に関連する骨髄関連細胞

Also Published As

Publication number Publication date
CN100402654C (zh) 2008-07-16
CN1777678A (zh) 2006-05-24
US20070036756A1 (en) 2007-02-15
EP1600511A4 (en) 2006-08-23
EP1600511A1 (en) 2005-11-30
WO2004074494A1 (ja) 2004-09-02
JPWO2004074494A1 (ja) 2006-06-01
CA2516486A1 (en) 2004-09-02
KR20050111593A (ko) 2005-11-25

Similar Documents

Publication Publication Date Title
ZA200508427B (en) Methods for treating interleuking-6 related diseases
EP1655036A4 (en) METHOD OF TREATING ONCOLOGICAL DISEASES
EP1636359A4 (en) METHODS OF TREATING PAIN
IL175818A0 (en) Method for treating adamts-5- associated disease
EP1696877A4 (en) PROCESS FOR PAIN TREATMENT
IL164352A0 (en) Methods for treating tweak-related conditions
EP1622609A4 (en) METHODS OF TREATING DEGENERATIVE DISEASES / LESIONS
HK1093892A1 (en) Compounds for treating ischemic related conditions
HK1092180A1 (en) Methods for treating ischemic diseases
GB0306432D0 (en) Process
EP1677816A4 (en) THERAPEUTIC METHOD
GB0316756D0 (en) Process
GB0317229D0 (en) Improved process
GB0311725D0 (en) Process
GB0307259D0 (en) Process
GB0307544D0 (en) Treatment method
GB0312122D0 (en) Therapeutic method
GB0302691D0 (en) Treatment method
GB0300733D0 (en) Process
GB0308672D0 (en) Process
AU2003300471A8 (en) Methods for treating ocular diseases
ZA200604552B (en) Method for treating ADAMTS-5-associated disease
GB0301124D0 (en) Therapeutic methods
GB0303430D0 (en) Treatment methods
GB0315322D0 (en) Treatment methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120130